ERAS - Erasca, Inc. Stock Price, Fair Value and News

$1.42-0.11 (-7.19%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

ERAS Price Action

Last 7 days

10.9%

Last 30 days

-10.7%

Last 90 days

-52.0%

Trailing 12 Months

-37.7%

ERAS RSI Chart

ERAS Valuation

Market Cap

401.5M

Price/Earnings (Trailing)

-2.52

Price/Free Cashflow

-3.66

ERAS Price/Earnings (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

ERAS Fundamentals

ERAS Earnings

Earnings (TTM)

-159.1M

Earnings Growth (Yr)

-2.76%

Earnings Growth (Qtr)

50.63%

ERAS Profitability

Return on Equity

-35.36%

Return on Assets

-30.09%

Free Cashflow Yield

-27.35%

ERAS Investor Care

Shares Dilution (1Y)

87.13%

Diluted EPS (TTM)

-0.82

Revenue & Growth

About Erasca, Inc.

Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; and ERAS-601, an oral SHP2 inhibitor for patients with advanced or metastatic solid tumors. It is also developing ERAS-801, a central nervous system-penetrant EGFR inhibitor for the treatment of patients with recurrent glioblastoma multiforme. The company was incorporated in 2018 and is headquartered in San Diego, California.

CEO	Dr. Jonathan E. Lim M.D.
WEBSITE	erasca.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	129

Erasca, Inc. Frequently Asked Questions

What is the ticker symbol for Erasca, Inc.? What does ERAS stand for in stocks?

ERAS is the stock ticker symbol of Erasca, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Erasca, Inc. (ERAS)?

As of Mon Mar 10 2025, market cap of Erasca, Inc. is 401.47 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ERAS stock?

You can check ERAS's fair value in chart for subscribers.

Is Erasca, Inc. a good stock to buy?

The fair value guage provides a quick view whether ERAS is over valued or under valued. Whether Erasca, Inc. is cheap or expensive depends on the assumptions which impact Erasca, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ERAS.